Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus
- PMID: 18225983
- DOI: 10.1086/526528
Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus
Comment on
-
A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.Clin Infect Dis. 2008 Mar 1;46(5):647-55. doi: 10.1086/526527. Clin Infect Dis. 2008. PMID: 18225981 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical